Stock Taper
SCREENER COMPARE ANY 2 STOCKS
BCTXZ
BRIACELL THERAPEUTICS CORP. WARRANT
NASDAQ
$0.14
▲ UP 12.31% (0.01)

KEY STATISTICS

Market Cap$254.31 K
52w High$0.16
52w Low$0.13
Dividend Yield—
Frequency—
P/E—
Volume13.36K
Shares Out.1.88M

COMPANY

LEADERSHIP

William V. Williams
CHIEF EXECUTIVE
William V. Williams

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 25, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
16

PRICE

$0.14 ▲ UP 12.31% (+$0.01)
$0.13$0.14$0.151:51 PM2:12 PM2:33 PM2:55 PM3:16 PM3:37 PM3:58 PM0.14

About BriaCell Therapeutics Corp. Warrant

https://www.briacell.com ↗

BriaCell Therapeutics, a Canadian biotech focused on immuno-oncology, develops cancer immunotherapies like Bria-IMT and Bria-OTS, and diagnostic tests, with collaborations including Incyte and the NCI.

INDUSTRY

Biotechnology

A PRODUCT BRIACELL THERAPEUTICS CORP. WARRANT IS KNOWN FOR

Bria-IMT™
Bria-IMT™

Bria-IMT™ is a clinical-stage, FDA Fast Track-designated off-the-shelf immunotherapy in Phase 3 trials, developed by BriaCell to stimulate the immune system to target and destroy advanced metastatic breast cancer.

COMPETITORS

COMPETITOR
CRDL COMPARE
IKT COMPARE
KRRO COMPARE
STRO COMPARE
TKNO COMPARE

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book5
Overall Score2

SECTORS PEERS

PEERPRICE
VRAX$2.82COMPARE
AIMD$1.41COMPARE
MLEC$6.80COMPARE
ELAB$5.31COMPARE
ATXI$0.45COMPARE
NCEL$3.19COMPARE
DRMA$1.34COMPARE
XRTX$2.34COMPARE